Lista de obras -

7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier.

artículo científico publicado en 2013

A Combination of Neuropsychological, Neuroimaging, and Cerebrospinal Fluid Markers Predicts Conversion from Mild Cognitive Impairment to Dementia ⬇️

artículo científico publicado el 1 de enero de 2013

A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium

artículo científico publicado en 2016

A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms

scientific article published on 31 March 2020

A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).

artículo científico publicado en 2018

APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points

artículo científico publicado en 2019

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort

artículo científico publicado en 2018

Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome

artículo científico publicado en 2014

Alzheimer's disease CSF biomarkers: clinical indications and rational use.

artículo científico publicado en 2017

Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

artículo científico publicado en 2016

Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment

artículo científico

An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease

artículo científico publicado en 2018

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

article

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and F-FDG-PET imaging

artículo científico publicado en 2019

CFAI-Plus: Adding cognitive frailty as a new domain to the comprehensive frailty assessment instrument

artículo científico publicado en 2018

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

artículo científico publicado en 2016

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

artículo científico publicado en 2016

CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment

artículo científico publicado en 2015

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis

artículo científico publicado en 2018

Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years

artículo científico publicado en 2015

Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease ⬇️

artículo científico publicado el 1 de enero de 2011

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

artículo científico publicado en 2017

Cerebrospinal fluid biomarkers mirror rate of cognitive decline

artículo científico

Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy

artículo científico publicado en 2014

Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease ⬇️

artículo científico publicado el 21 de agosto de 2012

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

artículo científico publicado en 2010

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

artículo científico publicado en 2019

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

artículo científico publicado en 2018

Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients

artículo científico publicado en 2014

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

artículo científico publicado en 2014

Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study

artículo científico publicado en 2012

Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings

artículo científico publicado en 2015

Monocyte and microglial activation in patients with mood-stabilized bipolar disorder

artículo científico publicado en 2015

Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment

artículo científico publicado en 2014

Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study

artículo científico publicado en 2015

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke

artículo científico publicado en 2017

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study

artículo científico publicado en 2018

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

artículo científico publicado en 2010

Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke

artículo científico publicado en 2014

No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis

artículo científico publicado en 2017

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease

artículo científico publicado en 2015

Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development

artículo científico publicado en 2007

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

artículo científico publicado en 2016

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

artículo científico publicado en 2016

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease

artículo científico publicado en 2017

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease

artículo científico publicado en 2013

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

artículo científico

Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis

scientific article published on 18 December 2019

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel

artículo científico publicado en 2017

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

artículo científico publicado en 2013

Subcortical vascular dementia biomarker pattern in mild cognitive impairment

artículo científico publicado en 2009

Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI Study

artículo científico publicado en 2017

T-Tau is Associated with Objective Memory Decline Over Two Years in Persons Seeking Help for Subjective Cognitive Decline: A Report from the Gothenburg-Oslo MCI Study

artículo científico publicado en 2015

The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting

artículo científico publicado en 2017

The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

artículo científico publicado en 2015

Lista de obras de

7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier.

A Combination of Neuropsychological, Neuroimaging, and Cerebrospinal Fluid Markers Predicts Conversion from Mild Cognitive Impairment to Dementia ⬇️

A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium

A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms

A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).

APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort

Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome

Alzheimer's disease CSF biomarkers: clinical indications and rational use.

Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment

An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and F-FDG-PET imaging

CFAI-Plus: Adding cognitive frailty as a new domain to the comprehensive frailty assessment instrument

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis

Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years

Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease ⬇️

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Cerebrospinal fluid biomarkers mirror rate of cognitive decline

Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy

Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease ⬇️

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration

Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study

Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings

Monocyte and microglial activation in patients with mood-stabilized bipolar disorder

Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment

Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke

No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease

Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

Relation between Heart Rate Variability and Disease Course in Multiple Sclerosis

Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

Subcortical vascular dementia biomarker pattern in mild cognitive impairment

Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI Study

T-Tau is Associated with Objective Memory Decline Over Two Years in Persons Seeking Help for Subjective Cognitive Decline: A Report from the Gothenburg-Oslo MCI Study

The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting

The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects